AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
08 Apr 2010 07:00 AM
RNS
Transaction in Own Shares
07 Apr 2010 07:00 AM
RNS
Transaction in Own Shares
06 Apr 2010 07:00 AM
RNS
Transaction in Own Shares
01 Apr 2010 04:00 PM
RNS
Total Voting Rights
01 Apr 2010 04:00 PM
RNS
Director/PDMR Shareholding
01 Apr 2010 07:00 AM
RNS
Transaction in Own Shares
31 Mar 2010 05:00 PM
RNS
Director/PDMR Shareholding
31 Mar 2010 05:00 PM
RNS
Director/PDMR Shareholding
30 Mar 2010 04:30 PM
RNS
Share RePurchase Programme
30 Mar 2010 01:00 PM
RNS
US FDA Issues CRL for Certria
30 Mar 2010 07:00 AM
RNS
Transaction in Own Shares
29 Mar 2010 04:30 PM
RNS
Director/PDMR Shareholding
29 Mar 2010 07:00 AM
RNS
Transaction in Own Shares
26 Mar 2010 07:00 AM
RNS
Transaction in Own Shares
25 Mar 2010 07:00 AM
RNS
Transaction in Own Shares
18 Mar 2010 02:34 PM
RNS
Seroquel Trial Update
18 Mar 2010 07:00 AM
RNS
Transaction in Own Shares
15 Mar 2010 11:00 AM
RNS
Directorate Change
15 Mar 2010 11:00 AM
RNS
Annual Financial Report
15 Mar 2010 09:00 AM
RNS
Emerging Markets Event
11 Mar 2010 04:30 PM
RNS
Director/PDMR Shareholding
11 Mar 2010 07:00 AM
RNS
Torrent Supply and Manufactur
09 Mar 2010 07:00 AM
RNS
Transaction in Own Shares
08 Mar 2010 07:00 AM
RNS
Recentin Horizon III Study Re
05 Mar 2010 05:00 PM
RNS
Director/PDMR Shareholding
03 Mar 2010 04:30 PM
RNS
Director/PDMR Shareholding
01 Mar 2010 04:30 PM
RNS
Total Voting Rights
01 Mar 2010 12:00 PM
RNS
Update re Arrangements with M
26 Feb 2010 04:30 PM
RNS
Director/PDMR Shareholding
26 Feb 2010 04:30 PM
RNS
Director/PDMR Shareholding
24 Feb 2010 04:30 PM
RNS
Director/PDMR Shareholding
24 Feb 2010 04:30 PM
RNS
Director/PDMR Shareholding
23 Feb 2010 07:00 AM
RNS
UK tax settlement on transfer
23 Feb 2010 07:00 AM
RNS
Transaction in Own Shares
16 Feb 2010 07:00 AM
RNS
AZ in deal for rheumatoid art
09 Feb 2010 07:00 AM
RNS
FDA approves new indication f
01 Feb 2010 04:30 PM
RNS
Total Voting Rights
01 Feb 2010 04:00 PM
RNS
Director/PDMR Shareholding
28 Jan 2010 11:00 AM
RNS
Final Results (Part 3 of 3)
28 Jan 2010 11:00 AM
RNS
Final Results (Part 2 of 3)
28 Jan 2010 11:00 AM
RNS
Final Results (Part 1 of 3)
27 Jan 2010 04:00 PM
RNS
Director/PDMR Shareholding
27 Jan 2010 09:00 AM
RNS
Notice of Results
07 Jan 2010 07:00 AM
RNS
AZ agreement with Teva on US
04 Jan 2010 04:00 PM
RNS
Total Voting Rights
24 Dec 2009 07:01 AM
RNS
Complete Response Letter on M
23 Dec 2009 03:00 PM
RNS
Acquisition
16 Dec 2009 07:00 AM
RNS
FDA AdCom favourable vote on
11 Dec 2009 03:56 PM
RNS
FDA posts Crestor briefing ma
08 Dec 2009 04:00 PM
RNS
Holding(s) in Company

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100